Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging SARS-CoV-2 variants: Why, how, and what's next?
Yu Chen, Qianyun Liu, Li Zhou, et al.
Cell Insight (2022) Vol. 1, Iss. 3, pp. 100029-100029
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
Qian Wang, Yicheng Guo, Sho Iketani, et al.
Nature (2022) Vol. 608, Iss. 7923, pp. 603-608
Open Access | Times Cited: 714
Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages
Shuai Xia, Lijue Wang, Yun Zhu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 137
Fast and sensitive CRISPR detection by minimized interference of target amplification
Xiaohan Tong, Kun Zhang, Yang Han, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 7, pp. 885-893
Closed Access | Times Cited: 31
Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages
Harold Marcotte, Yunlong Cao, Fanglei Zuo, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 3
Open Access | Times Cited: 21
Tuberculosis vaccines and therapeutic drug: challenges and future directions
Yajing An, Ruizi Ni, Zhuang Li, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 3
The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development
Zhen Zhang, Li Zhou, Qianyun Liu, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4, and BA.5
Qian Wang, Yicheng Guo, Sho Iketani, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 32
Comparative Review of the State of the Art in Research on the Porcine Epidemic Diarrhea Virus and SARS-CoV-2, Scope of Knowledge between Coronaviruses
Nora Hilda Rosas-Murrieta, Alan Rodríguez-Enríquez, Irma Herrera‐Camacho, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 238-238
Open Access | Times Cited: 7
A broad neutralizing nanobody against SARS-CoV-2 engineered from an approved drug
Qianyun Liu, Yuchi Lu, Chenguang Cai, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 6
ACE2-using merbecoviruses: Further evidence of convergent evolution of ACE2 recognition by NeoCoV and other MERS-CoV related viruses
Qing Xiong, Chengbao Ma, Chen Liu, et al.
Cell Insight (2024) Vol. 3, Iss. 1, pp. 100145-100145
Open Access | Times Cited: 5
Optimizing antigen selection for the development of tuberculosis vaccines
Yang Yang, Yizhen Chen, Tian Xia
Cell Insight (2024) Vol. 3, Iss. 3, pp. 100163-100163
Open Access | Times Cited: 4
Epitranscriptomic m 5 C methylation of SARS-CoV-2 RNA regulates viral replication and the virulence of progeny viruses in the new infection
Hongyun Wang, Jiangpeng Feng, Zhiying Fu, et al.
Science Advances (2024) Vol. 10, Iss. 32
Open Access | Times Cited: 4
Structure-guided mutations in CDRs for enhancing the affinity of neutralizing SARS-CoV-2 nanobody
Vishakha Singh, Mandar Bhutkar, Shweta Choudhary, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 734, pp. 150746-150746
Closed Access | Times Cited: 4
Anti-Viral Activity of Polyherbal Siddha Formulation “<i>Notchi kudineer</i>” Using Immuno-Fluorescence Assay and <i>In-Silico</i> Binding Studies of its Phytocompounds Against Various NSPs of SARS-CoV-2
Kabilan Natarajan, S. Joseph Maria Adaikalam, Sudha Seshayyan, et al.
Toxicology International (2025), pp. 101-110
Closed Access
Determinants of COVID‐19 Vaccination Status and Vaccine Hesitancy in the Centre‐Est Region of Burkina Faso: A Population‐Based Cross‐Sectional Study
Kadari Cissé, Eric Ismaël Zoungrana, Abdou Azaque Zouré, et al.
Advances in Public Health (2025) Vol. 2025, Iss. 1
Open Access
Development of de-novo coronavirus 3-chymotrypsin-like protease (3CLpro) inhibitors since COVID-19 outbreak: A strategy to tackle challenges of persistent virus infection
Lei Tian, Taotao Qiang, Xiuding Yang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115979-115979
Closed Access | Times Cited: 10
Evolution of a Distinct SARS-CoV-2 Lineage Identified during an Investigation of a Hospital Outbreak
Hosoon Choi, Munok Hwang, Lisa Cornelius, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 337-337
Open Access | Times Cited: 3
Exploring COVID-19 vaccine uptake and hesitancy among vulnerable populations in inner city Vancouver, Canada: Insights into characteristics and clinical outcomes
Saina Beitari, Shana Yi, Shawn Sharma, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 125904-125904
Closed Access | Times Cited: 3
Molecular insights into the inhibition mechanism of harringtonine against essential proteins associated with SARS-CoV-2 entry
Zhiwei Yang, Xinyue Fu, Yizhen Zhao, et al.
International Journal of Biological Macromolecules (2023) Vol. 240, pp. 124352-124352
Open Access | Times Cited: 9
Broadly neutralizing antibodies derived from the earliest COVID-19 convalescents protect mice from SARS-CoV-2 variants challenge
Qianyun Liu, Haiyan Zhao, Zhiqiang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 9
Evolution of SARS‐CoV‐2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID‐19 in an Italian reference hospital: Impact on clinical outcomes
Annalisa Mondi, Ilaria Mastrorosa, Pierluca Piselli, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Open Access | Times Cited: 7
USP2 inhibition prevents infection with ACE2-dependent coronaviruses in vitro and is protective against SARS-CoV-2 in mice
Fabin Dang, Lei Bai, Jiazhen Dong, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 725
Closed Access | Times Cited: 7
SARS-CoV-2 NSP14 governs mutational instability and assists in making new SARS-CoV-2 variants
Sk. Sarif Hassan, T. K. Bhattacharya, Debaleena Nawn, et al.
Computers in Biology and Medicine (2024) Vol. 170, pp. 107899-107899
Open Access | Times Cited: 2
Study on the correlation between DPP9 rs2109069 and IFNAR2 rs2236757 polymorphisms with COVID-19 mortality
Mahnaz Safari, Rezvan Tavakoli, Mohammad Reza Aghasadeghi, et al.
Nucleosides Nucleotides & Nucleic Acids (2024), pp. 1-16
Closed Access | Times Cited: 2
Detection and Characterisation of SARS-CoV-2 in Eastern Province of Zambia: A Retrospective Genomic Surveillance Study
Doreen Mainza Shempela, Herman M. Chambaro, Jay Sikalima, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6338-6338
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top